Paediatric HIV drug

THE Therapeutic Goods
Administration has approved HIV
treatment Telzir (fosamprenavir) for
use in children and adolescents
living with HIV.
Telzir in combination with lowdose
ritonavir is indicated for the
treatment of HIV-1 in infected
adults, adolescents and children of
six years and above in combination
with other anti-retroviral drugs.
Fosamprenavir is a protease
inhibitor, and has been available in
Australia since 2004.